Kashyap Tele-Medicines Ltd - 531960 - CODE OF PRACTICE AND PROCEDURE FOR FAIR DISCLOSURE OF UNPUBLISHED PRICE SENSITIVE INFORMATION
Pursuant to Regulation 8(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, please find enclosed herewith amended Code of Practice and Procedure for Fair Disclosure of Unpublished Price Sensitive Information duly approved by the Board of Directors of the Company. Kashyap Tele-Medicines Ltd - 531960 - Announcement under Regulation 30 (LODR)-Change in Directorate
1. Appointment of Mr. Raghav Agrawal (DIN: 02264149) as an Additional Director - Non Executive Non Independent Director of the Company w.e.f. 21st May, 2019, to be further regularize as a Director subject to the approval of the Members at the ensuing Annual General Meeting of the Company. 2. Appointment of Mr. Mayank Khetan (DIN: 02412971) as an Additional Director-Independent Director of the Company for the term of 5 (five) years w.e.f. 21st May, 2019 upto 20th May, 2024, to be further regularize as a Director subject to the approval of the Members at the ensuing Annual General Meeting of the Company. Kashyap Tele-Medicines Ltd - 531960 - Announcement under Regulation 30 (LODR)-Resignation of Director
1. Resignation of Mr. Girwarsingh Shekhawat (DIN: 06940371), as a Non Executive Independent Director of the Company, vide his resignation letter dated 11th May, 2019, due to personal and unavoidable circumstances w.e.f. 21st May, 2019. Further, Mr. Girwarsingh Shekhawat has confirmed that there is no other material reason for his resignation as Director of the Company, other than those cited above. 2. Resignation of Mr. Dinesh Ghewar Chand Jain (DIN: 00216803), as a Non Executive Non Independent Director of the Company, vide his resignation letter dated 11th May, 2019, due to personal preoccupations w.e.f. 21st May, 2019. Kashyap Tele-Medicines Ltd - 531960 - Submission Of Audited Financial Results Of The Company And Auditor Report For The Quarter And Year Ended 31St March, 2019
With reference to above, we are pleased to submit herewith, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Audited Financial Results of the Company for the quarter and year ended 31st March, 2019, prepared in accordance with Companies (Indian Accounting Standards) Rules, 2015 (IND-AS), as reviewed by the Audit Committee and subsequently approved by the Board of Directors of the Company at their respective in meeting held on 20th May, 2019. Also please find enclosed herewith the Auditor's Report of the said Audited Financial Results of the Company for the quarter and year ended 31st March, 2019 as received from the Auditors of the Company. Kashyap Tele-Medicines Ltd - 531960 - Outcome of Board Meeting
Outcome of Board Meeting held on 20th May, 2019 as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Kashyap Tele-Medicines Ltd - 531960 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Kashyap Tele-Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2019 ,inter alia, to consider and approve the Audited Financial Results for quarter and year ended 31st March, 2019 as per Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and to transact all such other businesses as per the agenda items of the Meeting. Kashyap Tele-Medicines Ltd - 531960 - Compliances-Certificate under Reg. 54 (5) of SEBI (DP) Regulations, 1996
With reference to above, we hereby enclose the confirmation certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March, 2019 received from Link Intime India Private Limited, Registrar and Share Transfer Agent of the Company. Kashyap Tele-Medicines Ltd - 531960 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayKashyap Tele-Medicines Ltd 2CININE108B01029 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: PRERNA KAKKAR Designation: Company Secretary EmailId: investor.relations@jindalonline.com Name of the Chief Financial Officer: DINESH JAIN Designation: CFO EmailId: djain_ca@rediffmail.com Date: 29/04/2019 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. Kashyap Tele-Medicines Ltd - 531960 - COMPLIANCE CERTIFICATE UNDER REGULATION 7(3) OF THE SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015 FOR THE HALF YEAR ENDED 31ST MARCH, 2019
With reference to above, enclosed please find Compliance Certificate duly signed by the Compliance Officer of the Company and the Authorised Representative of the Share Transfer Agent of the Company for the half year ended 31st March, 2019 as per Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.